Phase I Studies in Patient Populations:De-risking Clinical Development by Obtaining Key Patient Data Earlier
In this webinar members of our specialist, early phase Project Management team discuss how they tackled the range of challenges…
Webinars
Discover the latest in clinical development, trials and data management, from our in-house experts, available on demand now.
Time for a Clinical Trials Revolution – Complex Innovative Design (CID) Cancer Trials
Click to view This 1-hour webinar will review a published consensus statement from the British Journal of Cancer (BJC), looking at recommendations for effective delivery of Complex Innovative Design (CID) cancer trials. The traditional cancer drug development pathway is being superseded by trials that address multiple clinical questions. CID trials…
Rare Disease & Orphan Drug Development - Cost-efficient trial design to minimise cash burn
Click to view Discussion topics include: Key challenges to improve cost-efficiency in clinical development of orphan drugs Regulatory evolution in…
Effective Implementation of the Revised EMA First-into-Human (FiH) Guidance to Accelerate Your Early Clinical Development
Available to view on demand. In this webinar the speakers discuss the use of integrated protocols (umbrella protocols) to maximise programme…
Scintigraphy: Providing Critical Data in Early Clinical Development
Available to view on demand. If you are embarking on your clinical development plan, consider a non-invasive in vivo evaluation of drug…
Conducting Early Phase Oncology Studies - Successfully moving through to proof of concept and beyond
Available to view on demand. This one-hour webinar focuses on strategic considerations for the molecule, including a brief review of the…
Agility In Rare Diseases & Oncology Clinical Trials - Data Management
Available to view on demand. Modular and adaptive clinical trials are rapidly expanding the ability of researchers to modify clinical…
Achieving Orphan Designation (ODD) - Meeting the unmet need
Available to view on demand. Achieving Orphan Drug Designation is a significant step enabling your product to be licensed faster, in a cost-efficient…
ESMO Update: State of the Art in Early Phase Oncology Trial Design
If you missed our live ESMO Update: State of the Art in Early Phase Oncology Trial Design webinar you can…